Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Metformin in Patients With Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms

NCT07693452 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT07693452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07693452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Metformin in Patients With Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms
Lead sponsor
University of California, Irvine
Phase
Phase 2
Overall status
Recruiting
Start date
June 18, 2026
Completion date
July 31, 2029
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

appendiceal mucinous neoplasm, pseudomyxoma peritonei